Recap: Electromed Q2 Earnings
$ELMD
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Electromed (AMEX:ELMD) reported its Q2 earnings results on Tuesday, February 13, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Electromed beat estimated earnings by 90.0%, reporting an EPS of $0.19 versus an estimate of $0.1.
Revenue was up $1.96 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.08 which was followed by a 2.09% increase in the share price the next day.
Here's a look at Electromed's past performance:
| Quarter | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|
| EPS Estimate | 0.10 | 0.10 | 0.03 | |
| EPS Actual | 0.02 | 0.12 | 0.12 | 0.11 |
| Revenue Estimate | 12.60M | 12.80M | 12.05M | 11.05M |
| Revenue Actual | 12.32M | 13.61M | 12.07M | 11.73M |
To track all earnings releases for Electromed visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.